160 related articles for article (PubMed ID: 38390260)
1. Malignant mixed mullerian tumors: a SEER database review of rurality and treatment modalities on disease outcome.
Zadeh N; Bhatt A; Sripiparu V; Pasli M; Edwards G; Larkins MC; Peach MS
Front Oncol; 2024; 14():1296496. PubMed ID: 38390260
[TBL] [Abstract][Full Text] [Related]
2. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
3. Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.
Felix AS; Stone RA; Bowser R; Chivukula M; Edwards RP; Weissfeld JL; Linkov F
Int J Gynecol Cancer; 2011 Jul; 21(5):877-84. PubMed ID: 21666484
[TBL] [Abstract][Full Text] [Related]
4. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
5. Malignant mixed müllerian tumor of primary mesenteric origin associated with a synchronous ovarian cancer: case report and literature review.
Ma CJ; Yang SF; Huang CC; Chai CY; Cheng KI; Tsai EM; Wang JY
Eur J Gynaecol Oncol; 2008; 29(3):289-93. PubMed ID: 18592799
[TBL] [Abstract][Full Text] [Related]
6. A clinical and biological comparison between malignant mixed müllerian tumors and grade 3 endometrioid endometrial carcinomas.
Bland AE; Stone R; Heuser C; Shu J; Jazaeri A; Shutter J; Atkins K; Rice L
Int J Gynecol Cancer; 2009 Feb; 19(2):261-5. PubMed ID: 19396006
[TBL] [Abstract][Full Text] [Related]
7. Malignant mixed Mullerian tumour of the uterus.
Rajshekar SK; Guruprasad B; Shakunthala P; Rathod P; Devi U; Bafna U
Ecancermedicalscience; 2013; 7():302. PubMed ID: 23589731
[TBL] [Abstract][Full Text] [Related]
8. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes.
Garg G; Shah JP; Kumar S; Bryant CS; Munkarah A; Morris RT
Int J Gynecol Cancer; 2010 Jul; 20(5):888-94. PubMed ID: 20606539
[TBL] [Abstract][Full Text] [Related]
9. Clinical Profile and Treatment Outcomes of Malignant Mixed Mullerian Tumors of the Uterus: A Single-Center Experience.
Vijayaraghavan N; Ravikumar D
Cureus; 2023 Oct; 15(10):e48079. PubMed ID: 38046506
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
11. Malignant mixed mullerian tumor of the cervix including components of a rhabdomyosarcoma: case report and literature review.
Lee SH; Kim J; Kim JH; Lee KH; Park JS; Hur SY
Eur J Gynaecol Oncol; 2010; 31(4):462-6. PubMed ID: 20882897
[TBL] [Abstract][Full Text] [Related]
12. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
13. Trends in Gynecologic Carcinosarcoma Based on Analysis of the Surveillance Epidemiology End Result (SEER) Database.
Lee JW; Ouh YT; Chang HK; Min KJ; Lee S; Hong JH; Song JY; Lee JK; Lee NW
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769835
[TBL] [Abstract][Full Text] [Related]
14. Staging MRI of uterine malignant mixed Müllerian tumors versus endometrial carcinomas with emphasis on dynamic enhancement characteristics.
Garza A; Elsherif SB; Faria SC; Sagebiel T; Sun J; Ma J; Bhosale PR
Abdom Radiol (NY); 2020 Apr; 45(4):1141-1154. PubMed ID: 31190089
[TBL] [Abstract][Full Text] [Related]
15. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma.
Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343
[TBL] [Abstract][Full Text] [Related]
16. Primary ovarian malignant mixed Müllerian tumor: a rare case report.
Jagtap SV; Jagtap SS; Gudur R; Billawaria S
Ther Adv Rare Dis; 2022; 3():26330040221107389. PubMed ID: 37180422
[TBL] [Abstract][Full Text] [Related]
17. Malignant mixed müllerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival.
George E; Lillemoe TJ; Twiggs LB; Perrone T
Int J Gynecol Pathol; 1995 Jan; 14(1):39-44. PubMed ID: 7883424
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors.
Zelmanowicz A; Hildesheim A; Sherman ME; Sturgeon SR; Kurman RJ; Barrett RJ; Berman ML; Mortel R; Twiggs LB; Wilbanks GD; Brinton LA
Gynecol Oncol; 1998 Jun; 69(3):253-7. PubMed ID: 9648597
[TBL] [Abstract][Full Text] [Related]
19. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
20. Impact of Treatment Modalities on Prognosis in Patients With Renal Collecting Duct Carcinoma: A Population-Based Study.
Qian X; Xu J; Liu C; Zhong M; Hong S; Qian C; Zhu J; Zhang J; Wang S
Front Oncol; 2022; 12():810096. PubMed ID: 35530344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
